COVID-19 Resources > COVID-19 Web Series > Pulmonary Manifestations

Webinar Slides

Wednesday, May 27
Pulmonary Manifestations of COVID-19

Dr. Cameron Kyle-Sidell will focus on the pulmonary complications of COVID19 including Acute Respiratory Distress Syndrome (ARDS). He will discuss the potential mechanisms of pulmonary injury caused by COVID19. He will review how day-to-day evolutions in the understanding of this disease has led to changes in the approach to treating COVID19 patients, and how the unknowns of COVID19 continue to challenge us at the bedside while provoking intense debate away from it. 

Dr. Keith Van Meter will discuss the potential role of hyperbaric oxygen therapy (HBO) in the treatment of Covid19 and how HBO affords a way to markedly increase dissolved oxygen in plasma and bridge a patient with needed oxygenation until recovery is possible.



 Guest Moderator

_-2020_COVID_Webinar_Presenters/Moreno_2.jpg                      

Lisa Moreno, MD MS MSCR FAAEM FIFEM
President, American Academy of Emergency Medicine (AAEM);
Professor of Emergency Medicine,
Director of Research and Director of Diversity,
Section of Emergency Medicine,
Louisiana State University Health Sciences, New Orleans, LA J                                                                                      


 Presenters

_-2020_COVID_Webinar_Presenters/Kyle_Sidell.jpg        

Beyond ARDS: The Search for a Model of COVID19 Lung Injury and
its Clinical Implications


Cameron Kyle-Sidell, MD
Emergency Medicine and Critical Care Medicine,
Maimonides Medical Center, New York, NY                                                                       

_-2020_COVID_Webinar_Presenters/Van_Meter.jpg              

Updates from the Front Lines: Hyperbaric Oxygen Therapy in COVID19

Keith W. Van Meter, MD, FACEP
Chief, Section of Emergency Medicine, Professor of Clinical Medicine,
Louisiana State University Health Sciences Center;
Clinical Professor of Surgery, Tulane School of Medicine, New Orleans, LA                                           

_-2020_COVID_Webinar_Presenters/Lavon.jpg        


Updates from the Front Lines: Israel Experience with COVID19


Ophir Lavon, MD 
Chairman, Israel Society of Toxicology;
Head, Clinical Pharmacology and Toxicology Unit,
Carmel Medical Center, Haifa, Israel                                                                                 
                                                                     

 



Series Partners

American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | European Association of Poison Centers and Clinical Toxicologists (EAPCCT) | Middle East & North Africa Clinical Toxicology Association (MENATOX)  

images/COVID Series LOGOS